DRW Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
DRW Securities's LLY Position: Q1 2026 in Review
DRW Securities reduced its Eli Lilly (LLY) stake by 91% in Q1 2026, selling an estimated $4.77M and leaving 459 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #698.
DRW Securities first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $9.1M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- DRW Securities held 459 shares of Eli Lilly worth $422K as of Q1 2026.
- DRW Securities sold 4,707 Eli Lilly shares in Q1 2026, an estimated $4.77M.
- Eli Lilly made up 0.01% of DRW Securities's portfolio in Q1 2026, its #698 holding.
- DRW Securities first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
- DRW Securities's Eli Lilly position peaked at $9.1M in Q1 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.